DE602005007871D1 - 8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4-methoxyphenyl)-1-methylethylü amino üäethyl -2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür - Google Patents

8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4-methoxyphenyl)-1-methylethylü amino üäethyl -2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür

Info

Publication number
DE602005007871D1
DE602005007871D1 DE602005007871T DE602005007871T DE602005007871D1 DE 602005007871 D1 DE602005007871 D1 DE 602005007871D1 DE 602005007871 T DE602005007871 T DE 602005007871T DE 602005007871 T DE602005007871 T DE 602005007871T DE 602005007871 D1 DE602005007871 D1 DE 602005007871D1
Authority
DE
Germany
Prior art keywords
hydroxy
chinolinone
oethyl
aee
methylethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005007871T
Other languages
English (en)
Inventor
Fausto Pivetti
Roberto Pighi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34963779&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005007871(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Publication of DE602005007871D1 publication Critical patent/DE602005007871D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60—N-oxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE602005007871T 2004-03-24 2005-03-24 8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4-methoxyphenyl)-1-methylethylü amino üäethyl -2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür Active DE602005007871D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04007045 2004-03-24
PCT/EP2005/003144 WO2005089760A1 (en) 2004-03-24 2005-03-24 8-hydroxy-5-[(-hydroxy-2-[[ (1r)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl] -2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation

Publications (1)

Publication Number Publication Date
DE602005007871D1 true DE602005007871D1 (de) 2008-08-14

Family

ID=34963779

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005007871T Active DE602005007871D1 (de) 2004-03-24 2005-03-24 8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4-methoxyphenyl)-1-methylethylü amino üäethyl -2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür

Country Status (30)

Country Link
US (1) US20070197586A1 (de)
EP (1) EP1729773B1 (de)
JP (1) JP2007530489A (de)
KR (1) KR20070001946A (de)
CN (2) CN1929840B (de)
AR (1) AR048339A1 (de)
AT (1) ATE399552T1 (de)
AU (1) AU2005224032A1 (de)
BR (1) BRPI0508213A (de)
CA (1) CA2560650A1 (de)
CY (1) CY1108323T1 (de)
DE (1) DE602005007871D1 (de)
DK (1) DK1729773T3 (de)
EA (1) EA010128B1 (de)
ES (1) ES2309739T3 (de)
HR (1) HRP20080495T3 (de)
IL (1) IL178227A0 (de)
MA (1) MA28549B1 (de)
MX (1) MXPA06010515A (de)
NO (1) NO20064274L (de)
NZ (1) NZ550010A (de)
PE (1) PE20060159A1 (de)
PL (1) PL1729773T3 (de)
PT (1) PT1729773E (de)
RS (1) RS50602B (de)
SI (1) SI1729773T1 (de)
TN (1) TNSN06249A1 (de)
UA (1) UA86221C2 (de)
WO (1) WO2005089760A1 (de)
ZA (1) ZA200607907B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1953143A1 (de) * 2007-01-30 2008-08-06 CHIESI FARMACEUTICI S.p.A. Verfahren zur Herstellung von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1H)-Chinolinon-Monohydrochlorid
EP2116536A1 (de) * 2008-05-07 2009-11-11 CHIESI FARMACEUTICI S.p.A. Kristallform von 8-Hydroxy-5-[(1r)-1-Hydroxy-2[[(1r)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1h)-Chinolinon-Monohydrochlorid
EP2116537A1 (de) 2008-05-07 2009-11-11 CHIESI FARMACEUTICI S.p.A. Polymorph von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-chinolinon Monohydrochlorid
WO2011015289A1 (en) 2009-08-04 2011-02-10 Chiesi Farmaceutici S.P.A. 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl] amino]ethyl]-2(1h)-quinolinone hemi-fumarate
EP2360147A1 (de) 2010-02-22 2011-08-24 CHIESI FARMACEUTICI S.p.A. Verfahren zur Herstellung von kristallinen Partikeln von einem Salz von 8-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1H)-chinolinon (Carmoterol)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
GB9603237D0 (en) * 1996-02-16 1996-04-17 Sandoz Ltd Organic compounds
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
WO2005013945A2 (en) * 2003-08-05 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and a betamimetic
EP1953143A1 (de) * 2007-01-30 2008-08-06 CHIESI FARMACEUTICI S.p.A. Verfahren zur Herstellung von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1H)-Chinolinon-Monohydrochlorid
EP2116536A1 (de) * 2008-05-07 2009-11-11 CHIESI FARMACEUTICI S.p.A. Kristallform von 8-Hydroxy-5-[(1r)-1-Hydroxy-2[[(1r)-2-(4-Methoxyphenyl)-1-Methylethyl]amino]ethyl]-2(1h)-Chinolinon-Monohydrochlorid
EP2116537A1 (de) * 2008-05-07 2009-11-11 CHIESI FARMACEUTICI S.p.A. Polymorph von 8-Hydroxy-5-[(1R)-1-Hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-chinolinon Monohydrochlorid

Also Published As

Publication number Publication date
US20070197586A1 (en) 2007-08-23
JP2007530489A (ja) 2007-11-01
ZA200607907B (en) 2008-04-30
CN1929840B (zh) 2010-12-08
AR048339A1 (es) 2006-04-19
AU2005224032A1 (en) 2005-09-29
CA2560650A1 (en) 2005-09-29
UA86221C2 (en) 2009-04-10
CY1108323T1 (el) 2014-02-12
DK1729773T3 (da) 2008-10-20
KR20070001946A (ko) 2007-01-04
ATE399552T1 (de) 2008-07-15
RS50602B (sr) 2010-05-07
ES2309739T3 (es) 2008-12-16
EP1729773A1 (de) 2006-12-13
NO20064274L (no) 2006-10-13
SI1729773T1 (sl) 2008-10-31
MXPA06010515A (es) 2007-03-30
PT1729773E (pt) 2008-09-29
WO2005089760A1 (en) 2005-09-29
PL1729773T3 (pl) 2008-12-31
EA010128B1 (ru) 2008-06-30
EP1729773B1 (de) 2008-07-02
CN101812017A (zh) 2010-08-25
IL178227A0 (en) 2006-12-31
CN1929840A (zh) 2007-03-14
HRP20080495T3 (en) 2008-11-30
BRPI0508213A (pt) 2007-07-17
EA200601531A1 (ru) 2007-04-27
NZ550010A (en) 2010-08-27
MA28549B1 (fr) 2007-04-03
PE20060159A1 (es) 2006-04-04
TNSN06249A1 (en) 2007-12-03

Similar Documents

Publication Publication Date Title
EP1723885A4 (de) Reinigungswerkzeug und verfahren zur herstellung von reinigungsteilen davon
DE602004029094D1 (de) Herstellungsverfahren dafür und schaumstoff und formkörper daraus
IL186820A0 (en) Inhibitors of microsomal triglyceride transfer protein and apo-b secretion
DE602005025091D1 (de) Piezooszillator und herstellungsverfahren dafür
DE602005011803D1 (de) Kombinationen aus antimuscarinischen mitteln und corticosteroiden
HK1112162A1 (en) Wig and method of manufacturing the same
EP1718781A4 (de) Poröses beschichtetes element und herstellungsverfahren dafür unter verwendung von kaltspray
EP1767288A4 (de) Gegossene hohle kurbelwelle und herstellungsverfahren dafür
DE602006017185D1 (de) Innenautozierteil und herstellungsverfahren dafür
DE602005009200D1 (de) Quecksilberfreisetzende zusammensetzungen und herstellungsverfahren dafür
EP1794533A4 (de) Wärmetauscher und herstellungsverfahren dafür
ATE402154T1 (de) Monohydrochloridsalz von 1-ä3-ä3-(4- chlorphenyl)propoxyüpropylüpiperidin
DE602005020158D1 (de) Glucanderivate und herstellungsverfahren dafür
DE602005008979D1 (de) Kristallisiertes silikonhaltiges polyethylenterephthalat und herstellungsverfahren dafür
DE602005020537D1 (de) Koplanarer Filter und zugehöriges Herstellungsverfahren
EP1853632A4 (de) Modifizierung von aminen und alkoholen
DK1890570T3 (da) Tandbørstehoved og fremgangsmåde til fremstilling deraf
EP1747494A4 (de) Brillen und herstellungsverfahren dafür
DE602005007871D1 (de) 8-hydroxy-5- ä(-hydroxy-2- ää (1r)-2-(4-methoxyphenyl)-1-methylethylü amino üäethyl -2(1h)-chinolinonmonohydrochlorid in kristalliner form und herstellungsverfahren dafür
HK1124172A1 (en) Semiconductor structure and method of manufacturing a semiconductor structure
EP1883404A4 (de) P38-hemmer und anwendungsverfahren dafür
GB2414108B (en) Active matrix substrate and method of manufacturing the same
DE602005017210D1 (de) Optisches Element und dessen Herstellungsverfahren
DE602004029768D1 (de) Target aus hafniumlegierung und dessen herstellungsverfahren
DE60236994D1 (de) Halbleiterbauelement und dessen Herstellungsverfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition